Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,419
archived clinical trials in
Pulmonary

Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa
Multi-center, Multi-national, Randomized, Placebo-Controlled Trial of Azithromycin in Subjects With Cystic Fibrosis 6-18 Years Old, Culture Negative for Pseudomonas Aeruginosa
Status: Enrolling
Updated:  7/24/2015
Alberta Children's Hospital
mi
from
Calgary,
Effect of Azithromycin on Lung Function in 6-18 Year-olds With Cystic Fibrosis (CF) Not Infected With P. Aeruginosa
Multi-center, Multi-national, Randomized, Placebo-Controlled Trial of Azithromycin in Subjects With Cystic Fibrosis 6-18 Years Old, Culture Negative for Pseudomonas Aeruginosa
Status: Enrolling
Updated: 7/24/2015
Alberta Children's Hospital
mi
from
Calgary,
Click here to add this to my saved trials
Outpatient Registry Trial of Respiratory Tract Infections in Adults
Randomized Aseptic Pharmacokinetic Pharmacodynamic Outpatient Registry Trial of Respiratory Tract Infections in Adults (RAPPORT)
Status: Enrolling
Updated:  7/27/2015
Western Kentucky Pulmonary Clinic
mi
from
Louisville, KY
Outpatient Registry Trial of Respiratory Tract Infections in Adults
Randomized Aseptic Pharmacokinetic Pharmacodynamic Outpatient Registry Trial of Respiratory Tract Infections in Adults (RAPPORT)
Status: Enrolling
Updated: 7/27/2015
Western Kentucky Pulmonary Clinic
mi
from
Louisville, KY
Click here to add this to my saved trials
Outpatient Registry Trial of Respiratory Tract Infections in Adults
Randomized Aseptic Pharmacokinetic Pharmacodynamic Outpatient Registry Trial of Respiratory Tract Infections in Adults (RAPPORT)
Status: Enrolling
Updated:  7/27/2015
Northshore Research Associates
mi
from
Slidell, LA
Outpatient Registry Trial of Respiratory Tract Infections in Adults
Randomized Aseptic Pharmacokinetic Pharmacodynamic Outpatient Registry Trial of Respiratory Tract Infections in Adults (RAPPORT)
Status: Enrolling
Updated: 7/27/2015
Northshore Research Associates
mi
from
Slidell, LA
Click here to add this to my saved trials
FMRI of Stress and Addictive Disorders
Functional Magnetic Resonance Imaging of Stress and Addictive Disorders
Status: Enrolling
Updated:  7/28/2015
Yale Stress Center
mi
from
New Haven, CT
FMRI of Stress and Addictive Disorders
Functional Magnetic Resonance Imaging of Stress and Addictive Disorders
Status: Enrolling
Updated: 7/28/2015
Yale Stress Center
mi
from
New Haven, CT
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Birmingham, AL
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Tucson, AZ
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Long Beach, CA
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Long Beach, CA
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Aurora, CO
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Aurora, CO
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Wilmington, DE
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Wilmington, DE
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
St. Petersburg, FL
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
St. Petersburg, FL
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Boise, ID
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Boise, ID
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Chicago, IL
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Indianapolis, IN
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Kansas City, KA
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Kansas City, KA
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Louisville, KY
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Louisville, KY
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Portland, ME
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Portland, ME
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Boston, MA
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Detroit, MI
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Detroit, MI
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Minneapolis, MN
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Minneapolis, MN
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Columbia, MO
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Columbia, MO
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Kansas City, MO
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Omaha, NE
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Rochester, NY
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Rochester, NY
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Akron, OH
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Akron, OH
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Toledo, OH
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Toledo, OH
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Portland, OR
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Portland, OR
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Philadelphia, PA
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Providence, RI
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Providence, RI
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Providence, RI
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Charleston, SC
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Charleston, SC
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Knoxville, TN
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Knoxville, TN
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Nashville, TN
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Nashville, TN
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Fort Worth, TX
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Houston, TX
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Charlottesville, VA
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Charlottesville, VA
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Spokane, WA
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Spokane, WA
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Morgantown, WV
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Morgantown, WV
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Cincinnati, OH
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Cincinnati, OH
Click here to add this to my saved trials
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated:  7/28/2015
Clinical Research Facility
mi
from
Seattle, WA
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
An Ocular Safety Study of Ivacaftor-Treated Pediatric Patients 11 Years of Age or Younger With Cystic Fibrosis
Status: Enrolling
Updated: 7/28/2015
Clinical Research Facility
mi
from
Seattle, WA
Click here to add this to my saved trials
Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)
Zinc Homeostasis and Kinetics in Children With CF
Status: Enrolling
Updated:  7/29/2015
Baylor College of Medicine
mi
from
Houston, TX
Zinc Homeostasis and Kinetics in Children With Cystic Fibrosis (CF)
Zinc Homeostasis and Kinetics in Children With CF
Status: Enrolling
Updated: 7/29/2015
Baylor College of Medicine
mi
from
Houston, TX
Click here to add this to my saved trials
Carvedilol for Psychostimulant Dependence
Clinical Efficacy of Carvedilol for Psychostimulant Dependence
Status: Enrolling
Updated:  7/29/2015
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Carvedilol for Psychostimulant Dependence
Clinical Efficacy of Carvedilol for Psychostimulant Dependence
Status: Enrolling
Updated: 7/29/2015
University of Arkansas for Medical Sciences
mi
from
Little Rock, AR
Click here to add this to my saved trials
Nefazodone in the Treatment of Cocaine Dependence and Depression - 4
Efficacy of Nefazodone in Cocaine Dependent Subjects
Status: Enrolling
Updated:  7/29/2015
Boston University
mi
from
Boston, MA
Nefazodone in the Treatment of Cocaine Dependence and Depression - 4
Efficacy of Nefazodone in Cocaine Dependent Subjects
Status: Enrolling
Updated: 7/29/2015
Boston University
mi
from
Boston, MA
Click here to add this to my saved trials
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated:  7/30/2015
Yale University
mi
from
New Haven, CT
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated: 7/30/2015
Yale University
mi
from
New Haven, CT
Click here to add this to my saved trials
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated:  7/30/2015
University of Indiana
mi
from
Indianapolis, IN
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Sleep Apnea in TIA/Stroke: Reducing Cardiovascular Risk With Positive Airway Pressure
Status: Enrolling
Updated: 7/30/2015
University of Indiana
mi
from
Indianapolis, IN
Click here to add this to my saved trials
A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation
A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
mi
from
Birmingham, AL
A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation
A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation
A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Status: Enrolling
Updated:  8/1/2015
Clinical Research Facility
mi
from
Anchorage, AK
A Study of Lumacaftor in Combination With Ivacaftor in Cystic Fibrosis Subjects Aged 12 Years and Older Who Are Homozygous for the F508del-CFTR Mutation
A Phase 3, Randomized, Double Blind, Placebo Controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lumacaftor in Combination With Ivacaftor in Subjects Aged 12 Years and Older With Cystic Fibrosis, Homozygous for the F508del CFTR Mutation
Status: Enrolling
Updated: 8/1/2015
Clinical Research Facility
mi
from
Anchorage, AK
Click here to add this to my saved trials